(Q34334926)

English

Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study

scientific article published on September 13, 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study (English)

1 reference

10.1200/JCO.2010.30.3446

https://api.crossref.org/works/10.1200/JCO.2010.30.3446

12 July 2024

chemoradiotherapy

0 references

pancreatic cancer

1 reference

based on heuristic

inferred from title

Eric Van Cutsem

14

object named as

Eric Van Cutsem

0 references

Jean-Luc Van Laethem

1

object named as

Jean-Luc Van Laethem

0 references

4

object named as

David Azria

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

2

object named as

Pascal Hammel

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20837948

12 July 2024

7

object named as

Marc Peeters

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20837948

12 July 2024

13

object named as

Manfred Lutz

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20837948

12 July 2024

Karin Haustermans

15

object named as

Karin Haustermans

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20837948

12 July 2024

author name string

Françoise Mornex

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Geertjan Van Tienhoven

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Philippe Vergauwe

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Marc Polus

8

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Michel Praet

9

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Murielle Mauer

10

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Laurence Collette

11

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Volker Budach

12

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

13 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

full work available at URL

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.30.3446?role=tab

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20837948

12 July 2024

http://intl.jco.org/cgi/content/abstract/28/29/4450

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20837948

12 July 2024

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20837948/pdf/?tool=EBI

Portable Document Format

online access status

content deliverer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20837948

12 July 2024

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20837948/?tool=EBI

online access status

content deliverer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20837948

12 July 2024

https://europepmc.org/articles/PMC2988636

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20837948

12 July 2024

https://europepmc.org/articles/PMC2988636?pdf=render

Portable Document Format

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20837948

12 July 2024

https://doi.org/10.1200/jco.2010.30.3446

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20837948

12 July 2024

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.30.3446

1 reference

10.1200/JCO.2010.30.3446

https://api.crossref.org/works/10.1200/JCO.2010.30.3446

12 July 2024

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

4450-4456

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Margin clearance and outcome in resected pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988636

6 July 2018

DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988636

6 July 2018

Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988636

6 July 2018

Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988636

6 July 2018

Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988636

6 July 2018

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988636

6 July 2018

Cancer statistics, 2006

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988636

6 July 2018

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988636

6 July 2018

Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988636

6 July 2018

Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988636

6 July 2018

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988636

6 July 2018

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988636

6 July 2018

Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988636

27 October 2018

Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988636

27 October 2018

Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988636

27 October 2018

Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988636

27 October 2018

Adjuvant gemcitabine and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: a multicenter Belgian Phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988636

27 October 2018

Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988636

27 October 2018

Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988636

27 October 2018

Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988636

27 October 2018

Most Pancreatic Cancer Resections are R1 Resections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2988636

9 December 2018

An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/20837948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incorporating toxicity considerations into the design of two-stage phase II clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/20837948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine

1 reference

https://pubmed.ncbi.nlm.nih.gov/20837948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of tumor radioresponse in vivo by gemcitabine

1 reference

https://pubmed.ncbi.nlm.nih.gov/20837948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maximizing therapeutic gain with gemcitabine and fractionated radiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20837948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20837948

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2010.30.3446

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34334926&oldid=2202132215"